Investors

Press Releases


All Releases
View Summary Trius Announces Issuance of Tedizolid Patent in China
Feb 16, 2012
PDF 9.3 KB Add to Briefcase
View Summary Trius to Present at the BIO CEO & Investor Conference
Feb 7, 2012
PDF 7.3 KB Add to Briefcase
View Summary Trius Therapeutics, Inc. Announces Exercise in Full of Underwriters' Option to Purchase Additional Shares for Common Stock Offering
Jan 30, 2012
PDF 10.3 KB Add to Briefcase
View Summary Trius Therapeutics, Inc. Prices Public Offering of Common Stock
Jan 26, 2012
PDF 11.1 KB Add to Briefcase
View Summary Trius Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
Jan 25, 2012
PDF 10.7 KB Add to Briefcase
View Summary Trius Earns $5 Million Milestone Payment From Bayer for Successful Completion of First Phase 3 Trial of Tedizolid
Jan 23, 2012
PDF 10.2 KB Add to Briefcase
View Summary Trius Reports Positive Results From First Phase 3 Trial of Tedizolid in Acute Bacterial Skin and Skin Structure Infections
Dec 19, 2011
PDF 13.1 KB Add to Briefcase
View Summary Trius to Host Analyst and Investor Day in New York
Nov 28, 2011
PDF 8.0 KB Add to Briefcase
View Summary Trius to Present at Piper Jaffray Healthcare Conference
Nov 22, 2011
PDF 6.9 KB Add to Briefcase
View Summary Trius Therapeutics Reports 2011 Third Quarter Financial Results
Nov 10, 2011
PDF 19.4 KB Add to Briefcase
View Summary Trius to Present at Credit Suisse Healthcare Conference
Nov 7, 2011
PDF 6.8 KB Add to Briefcase
View Summary Trius Therapeutics to Present at October 2011 Investor Conferences
Oct 17, 2011
PDF 7.1 KB Add to Briefcase
View Summary Trius Initiates Second Phase 3 Trial in Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
Sep 29, 2011
PDF 10.2 KB Add to Briefcase
View Summary Trius to Present at the JMP Securities Healthcare Conference
Sep 23, 2011
PDF 7.3 KB Add to Briefcase
View Summary Trius Announces Completion of Enrollment in Phase 3 Trial
Sep 15, 2011
PDF 9.1 KB Add to Briefcase
View Summary Trius Therapeutics to Present Data From Antibiotic Drug Development Programs at ICAAC
Sep 14, 2011
PDF 12.2 KB Add to Briefcase
View Summary Trius Therapeutics Reports 2011 Second Quarter Financial Results
Aug 11, 2011
PDF 17.6 KB Add to Briefcase
View Summary Trius to Present at Canaccord Genuity Growth Conference
Aug 5, 2011
PDF 6.8 KB Add to Briefcase
View Summary Trius Therapeutics Obtains Special Protocol Assessment With FDA for Second Phase 3 Study of Torezolid Phosphate
Aug 5, 2011
PDF 8.3 KB Add to Briefcase
View Summary Trius Therapeutics and Bayer Form Strategic Collaboration to Develop and Commercialize Torezolid Phosphate in Asia-Pacific and Emerging Markets
Jul 27, 2011
PDF 11.4 KB Add to Briefcase
Showing 1-20 of 67 Page: 1 2 3 4  Next 20
=add release to Briefcase